Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 13.30
+0.10 (0.76%)
At close: Jul 9, 2026
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.64 billion as of July 9, 2026. Its market cap has decreased by -24.25% in one year.
Market Cap
7.64B
Enterprise Value
4.09B
Revenue
185.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
13.30
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.64B, a decrease of -66.69%. That is a compound annual growth rate of -31.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.64B | -14.55% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 11.11B |
| Tanvex BioPharma | 10.73B |
| PharmaEngine | 9.14B |
| Locus Cell | 8.94B |
| Adimmune | 7.46B |
| Savior Lifetec | 6.60B |
| TaiGen Biopharmaceuticals Holdings | 6.48B |
| AnnJi Pharmaceutical | 6.42B |